Skip to content

Bnibt

by Beijing North Institute of Biotechnology Co., Ltd. China EUDAMED

Ref RFPDGS

EMDN W0102050106

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-06975456580281 Basic UDI-DIDate2 Nov 2022RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/IVDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 22 Oct 2026

Device Name
Progesterone Urine（PdG） Rapid Test
Model / Reference
RFPDGS
Primary DI / UDI-DI
06975456580281
Basic UDI-DI
B-06975456580281
EMDN Code
W0102050106 Progesterone
Device Class
Class IVD General
Market of Registration
Greece

Manufacturer details

EUDAMED SRN
CN-MF-000008259
Authorised representative
Lotus NL B.V. NL-AR-000000121

Other devices from Beijing North Institute of Biotechnology Co., Ltd.

See all devices from Beijing North Institute of Biotechnology Co., Ltd. →

Properties & raw data

Show properties, registry sources and raw records
  • Reagent
  • Near-Patient Testing
  • Professional Testing
Other properties (7)
  • Sterile: No
  • Human Tissues: No
  • Animal Tissues: No
  • Microbial Substances: No
  • Self Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No

Sources (1)

  • EUDAMED 2c876aed-d19a-40c8-bac7-c90f78aae0d1 61 fields · synced 22 Oct 2026